Information regarding the exercise period of warrants of series TO 1 in Genetic Analysis
Oslo, Norway, November 2, 2022 - On November 2, 2022, the exercise period for the warrants of series TO 1 issued in connection with Genetic Analysis AS's ("GA" or the "Company") IPO in September/October 2021 will commence. The exercise period runs until 16 November 2022. Holders of series TO 1 warrants are entitled to subscribe for one new share in the Company for each warrant at a price of NOK 9.30 per share - the closing price of GA's share as of 31 October was NOK 1.85 per share, which is significantly lower than the subscription price and thus something that option holders should be aware